Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLGNOTCMKTS:GTHPNASDAQ:MDAINASDAQ:POCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLGNCollPlant Biotechnologies$1.50+6.4%$2.03$1.35▼$5.48$17.93M1.7733,514 shs77,880 shsGTHPGuided Therapeutics$0.23$0.14$0.06▼$0.25$18.15M-0.113,448 shs5,934 shsMDAISpectral AI$2.10+2.4%$1.56$0.82▼$3.25$51.90M0.7863,106 shs473,415 shsPOCIPrecision Optics$4.60-0.9%$4.44$3.47▼$6.59$35.57M0.2115,447 shs13,005 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLGNCollPlant Biotechnologies-4.08%-14.55%-26.94%-49.64%-70.90%GTHPGuided Therapeutics0.00%0.00%+64.29%+177.11%+127.72%MDAISpectral AI-6.39%-0.49%+40.41%+45.39%+28.93%POCIPrecision Optics+6.42%+1.31%+4.88%+5.22%-21.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLGNCollPlant Biotechnologies1.8043 of 5 stars3.73.00.00.00.60.00.6GTHPGuided Therapeutics0.2696 of 5 stars0.03.00.00.00.61.70.0MDAISpectral AI3.6418 of 5 stars3.75.00.00.03.23.30.0POCIPrecision OpticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLGNCollPlant Biotechnologies 3.33Buy$11.50666.67% UpsideGTHPGuided Therapeutics 0.00N/AN/AN/AMDAISpectral AI 3.33Buy$4.75126.19% UpsidePOCIPrecision Optics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest GTHP, POCI, CLGN, and MDAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $12.004/2/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.503/27/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.00(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLGNCollPlant Biotechnologies$510K37.41N/AN/A$1.18 per share1.27GTHPGuided Therapeutics$10K1,814.93N/AN/A($0.12) per share-1.92MDAISpectral AI$29.58M1.80N/AN/A($0.32) per share-6.56POCIPrecision Optics$19.10M1.85N/AN/A$1.66 per share2.77Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLGNCollPlant Biotechnologies-$16.61M-$1.22N/AN/AN/A-560.92%-87.33%-65.31%7/16/2025 (Estimated)GTHPGuided Therapeutics-$2.42M-$0.05N/A∞N/AN/AN/A-197.32%8/12/2025 (Estimated)MDAISpectral AI-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%N/APOCIPrecision Optics-$2.95M-$0.89N/A∞N/A-32.84%-54.03%-32.48%N/ALatest GTHP, POCI, CLGN, and MDAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/4/2025Q1 2025CLGNCollPlant Biotechnologies-$0.37-$0.13+$0.24-$0.13$9.76 million$2.06 million5/15/2025Q1 2025GTHPGuided TherapeuticsN/A-$0.01N/A-$0.01N/AN/A5/15/2025Q3 2025POCIPrecision OpticsN/A-$0.30N/A-$0.30N/A$4.19 million3/31/2025Q4 2024GTHPGuided TherapeuticsN/A-$0.02N/A-$0.02N/AN/A3/27/2025Q4 2024MDAISpectral AI-$0.13-$0.06+$0.07-$0.41$6.83 million$7.60 million3/26/2025Q4 2024CLGNCollPlant Biotechnologies-$0.42-$0.34+$0.08-$0.34$0.36 million$0.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/AGTHPGuided TherapeuticsN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLGNCollPlant BiotechnologiesN/A4.484.23GTHPGuided TherapeuticsN/A0.140.03MDAISpectral AIN/A1.411.37POCIPrecision Optics0.111.991.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLGNCollPlant Biotechnologies21.69%GTHPGuided Therapeutics9.69%MDAISpectral AI67.08%POCIPrecision Optics13.71%Insider OwnershipCompanyInsider OwnershipCLGNCollPlant Biotechnologies9.60%GTHPGuided Therapeutics66.83%MDAISpectral AI30.70%POCIPrecision Optics16.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLGNCollPlant Biotechnologies7012.72 million11.50 millionOptionableGTHPGuided Therapeutics578.91 million26.18 millionNot OptionableMDAISpectral AI8325.32 million17.55 millionNot OptionablePOCIPrecision Optics807.67 million6.42 millionNot OptionableGTHP, POCI, CLGN, and MDAI HeadlinesRecent News About These CompaniesLaCroix Precision Optics Expands in Batesville, Arkansas, Creating 107 New JobsJune 5, 2025 | globenewswire.comPrecision Optics Expands Facilities to Meet Growing BacklogJune 5, 2025 | globenewswire.comPrecision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 27, 2025 | globenewswire.comPrecision Optics reports annual meeting resultsMay 25, 2025 | investing.comPrecision Optics Corporation: Precision Optics Reports Third Quarter Fiscal Year 2025 Financial ResultsMay 16, 2025 | finanznachrichten.dePrecision Optics Corporation, Inc. (POCI) Q1 2025 Earnings Conference Call TranscriptMay 15, 2025 | seekingalpha.comPrecision Optics Reports Third Quarter Fiscal Year 2025 Financial ResultsMay 15, 2025 | globenewswire.comPrecision Optics Market Global Forecast Report to 2030: Cumulative Impact of United States TariffsMay 14, 2025 | globenewswire.comPrecision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025May 8, 2025 | globenewswire.comPrecision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025April 21, 2025 | globenewswire.comPrecision Optics Signs Major Aerospace Deal, Expands Backlog To $6.6M With New OrdersApril 5, 2025 | nasdaq.comPrecision Optics enters into main purchase agreement with aerospace customerApril 4, 2025 | markets.businessinsider.comPrecision Optics to Participate in the Lytham [...]March 27, 2025 | aktiencheck.dePrecision Optics to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025March 27, 2025 | globenewswire.comPrecision Optics Appoints Joseph P. Pellegrino, Jr. to Board of DirectorsMarch 20, 2025 | globenewswire.comPrecision Optics Appoints Buell Duncan to Board of Directors; Dr. Richard Miles Retires from BoardMarch 4, 2025 | globenewswire.comPrecision Optics Announces Closing of $5.1 Million Offering of Common Stock to Fund Business ExpansionFebruary 24, 2025 | globenewswire.comPrecision Optics prices 1.27M shares at $4.00 in registered direct offeringFebruary 20, 2025 | markets.businessinsider.comPrecision Optics Announces Pricing of $5.1 Million Offering of Common Stock to Fund Business ExpansionFebruary 20, 2025 | finance.yahoo.comEarnings call transcript: Precision Optics Q2 FY2025 shows revenue dropFebruary 13, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGTHP, POCI, CLGN, and MDAI Company DescriptionsCollPlant Biotechnologies NASDAQ:CLGN$1.50 +0.09 (+6.38%) Closing price 03:59 PM EasternExtended Trading$1.44 -0.05 (-3.67%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.Guided Therapeutics OTCMKTS:GTHP$0.23 0.00 (0.00%) As of 03:26 PM EasternGuided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.Spectral AI NASDAQ:MDAI$2.10 +0.05 (+2.44%) Closing price 04:00 PM EasternExtended Trading$2.12 +0.02 (+1.00%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.Precision Optics NASDAQ:POCI$4.60 -0.04 (-0.86%) Closing price 04:00 PM EasternExtended Trading$4.66 +0.06 (+1.33%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
